Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $439,345 - $500,592
-2,749 Reduced 0.6%
453,514 $82.6 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $1.18 Million - $1.33 Million
-8,572 Reduced 1.84%
456,263 $70.7 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $1.01 Million - $1.17 Million
-7,542 Reduced 1.6%
464,835 $69.3 Million
Q2 2023

Aug 04, 2023

BUY
$132.51 - $164.9 $836,270 - $1.04 Million
6,311 Added 1.35%
472,377 $63.6 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $336,507 - $387,538
2,327 Added 0.5%
466,066 $74.3 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $1.33 Million - $1.59 Million
-9,592 Reduced 2.03%
463,739 $75 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $1.54 Million - $1.77 Million
-11,506 Reduced 2.37%
473,331 $63.5 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $1.89 Million - $2.41 Million
-13,765 Reduced 2.76%
484,837 $74.3 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $1.87 Million - $2.33 Million
-14,205 Reduced 2.77%
498,602 $80.8 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $342,916 - $433,888
-3,192 Reduced 0.62%
512,807 $69.4 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $2.76 Million - $3.14 Million
-25,981 Reduced 4.79%
515,999 $55.7 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $1.1 Million - $1.23 Million
-10,501 Reduced 1.9%
541,980 $61 Million
Q1 2021

May 07, 2021

SELL
$102.3 - $112.62 $1.15 Million - $1.26 Million
-11,220 Reduced 1.99%
552,481 $59.8 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $172 Million - $232 Million
-2,130,946 Reduced 79.08%
563,701 $60.4 Million
Q3 2020

Nov 04, 2020

SELL
$85.91 - $100.83 $39.4 Million - $46.3 Million
-459,158 Reduced 14.56%
2,694,647 $236 Million
Q2 2020

Aug 12, 2020

SELL
$73.37 - $98.18 $16.6 Million - $22.2 Million
-226,424 Reduced 6.7%
3,153,805 $310 Million
Q1 2020

May 04, 2020

SELL
$64.5 - $97.79 $75.8 Million - $115 Million
-1,175,771 Reduced 25.81%
3,380,229 $258 Million
Q4 2019

Feb 05, 2020

BUY
$72.13 - $90.25 $23.5 Million - $29.4 Million
325,232 Added 7.69%
4,556,000 $403 Million
Q3 2019

Nov 08, 2019

SELL
$62.98 - $75.72 $9.54 Million - $11.5 Million
-151,493 Reduced 3.46%
4,230,768 $320 Million
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $19.5 Million - $24.9 Million
-296,589 Reduced 6.34%
4,382,261 $319 Million
Q1 2019

May 06, 2019

SELL
$77.14 - $90.79 $17.6 Million - $20.7 Million
-228,016 Reduced 4.65%
4,678,850 $377 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $19.4 Million - $24 Million
-249,679 Reduced 4.84%
4,906,866 $452 Million
Q3 2018

Nov 09, 2018

SELL
$88.91 - $98.84 $12.9 Million - $14.3 Million
-145,023 Reduced 2.74%
5,156,545 $488 Million
Q2 2018

Aug 08, 2018

SELL
$89.78 - $106.23 $21 Million - $24.9 Million
-234,339 Reduced 4.23%
5,301,568 $491 Million
Q1 2018

May 07, 2018

SELL
$92.01 - $123.21 $5.61 Million - $7.51 Million
-60,939 Reduced 1.09%
5,535,907 $524 Million
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $192 Million - $210 Million
-2,141,066 Reduced 27.67%
5,596,846 $541 Million
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $540 Million - $690 Million
7,737,912
7,737,912 $688 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.